Learn About Frontotemporal Dementia

Introduction to Frontotemporal Dementia

When we think of dementia, we typically picture Alzheimer’s memory loss in the elderly. But dementia is a broad term, and some forms strike much earlier in life, attacking the very core of a person’s personality, behavior, and ability to communicate. This is the devastating reality of Frontotemporal Dementia (FTD), a group of brain disorders that results from the progressive degeneration of the brain’s frontal and temporal lobes. For families, the journey often begins not with forgetfulness, but with baffling and heartbreaking changes in their loved one’s character. A once-caring spouse may become emotionally distant and apathetic, or a once-reserved parent may begin to make inappropriate social comments. Understanding that these changes are not a midlife crisis or a psychological failing, but the symptoms of a neurodegenerative disease, is the first and most critical step in navigating the immense challenges of FTD.

What is Frontotemporal Dementia?

Frontotemporal Dementia (FTD), sometimes called frontotemporal degeneration, is an umbrella term for a group of uncommon brain disorders that primarily affect the frontal and temporal lobes of the brain. To understand the disease, it is essential to know what these parts of the brain control:

  • The Frontal Lobes, located behind your forehead, are the “executive suite” of your brain. They are responsible for personality, judgment, empathy, reasoning, planning, and controlling social behavior and impulses.
  • The Temporal Lobes, located behind your ears, are the brain’s primary language centers. They are responsible for understanding speech, producing language, and attaching meaning to words.

In FTD, nerve cells in these specific lobes shrink and die, and the pathways connecting them break down. As these regions of the brain atrophy, the abilities they control begin to diminish. Unlike Alzheimer’s disease, which typically starts in the brain’s memory centers, FTD begins by attacking the parts of the brain that make us who we are. This is why the first symptoms are often dramatic changes in personality and behavior or a progressive loss of language skills, while memory can remain relatively intact in the early stages.

I’ve often seen families struggle most with how sudden and strange the behavior changes seem, patients may act like a different person long before memory problems appear.

What causes Frontotemporal Dementia?

FTD is caused by the progressive death of neurons (nerve cells) in the frontal and temporal lobes. This cell death is caused by the abnormal buildup of certain proteins within the brain cells. When these proteins clump together, they become toxic, disrupt normal cell function, and eventually kill the neuron.

While research is ongoing, scientists have identified three main types of abnormal protein deposits that account for most cases of FTD:

  • Tau Protein: This protein normally helps stabilize the internal skeleton of neurons. In some forms of FTD, the tau protein becomes abnormal and forms toxic tangles within cells, a pathology also seen in Alzheimer’s disease. The classic form of FTD with tau pathology was historically known as Pick’s disease.
  • TDP-43 Protein: This is the most common protein abnormality in FTD. The TDP-43 protein normally helps regulate gene activity. In FTD, it moves from the cell’s nucleus to the cytoplasm and forms toxic clumps.
  • FUS Protein: In a smaller number of cases, clumps of a protein called FUS (Fused in Sarcoma) are the cause.

The specific protein that is accumulating determines the subtype of FTD, but why these proteins begin to misfold and clump together is not fully understood. In about 60% of cases, this process occurs for no known reason (sporadic FTD). In the other 40%, it is caused by a specific genetic mutation.

In my experience, understanding FTD’s protein basis helps families accept that it’s a biological disease, not a personality flaw. The brain is physically changing, not just aging.

How do you get Frontotemporal Dementia?

FTD can occur sporadically or be inherited.

A Strong Genetic Component

A key feature that distinguishes FTD from Alzheimer’s disease is its strong genetic link. Up to 40% of all people with FTD have a family history of the disease or a related neurodegenerative disorder.

  • Inheritance Pattern: When FTD is familial, it is almost always inherited in an autosomal dominant pattern. This means that inheriting a single copy of the mutated gene from one parent is enough to cause the disease. An affected parent has a 50% chance of passing the mutation on to each of their children.
  • Key Genes: The three most common genes known to cause hereditary FTD are:
    • C9orf72
    • MAPT (the gene that provides instructions for the tau protein)
    • GRN (the gene for progranulin)

Sporadic FTD

Despite the strong genetic link in many families, it is important to remember that for the majority of individuals (about 60%), FTD is sporadic. This means it occurs in someone with no known family history of the disorder. In these cases, the cause of protein buildup is unknown. There are no established environmental or lifestyle factors that have been proven to increase the risk of developing FTD.

Signs and symptoms of Frontotemporal Dementia

The specific symptoms of FTD depend on which part of the frontal and temporal lobes is most affected at the outset. The disease is broadly divided into two main clinical presentations.

1. Behavioral Variant FTD (bvFTD)

This is the most common form of FTD, accounting for about 60% of cases. It is characterized by progressive and profound changes in personality, social conduct, and behavior. These changes can be deeply distressing and confusing for family members.

  • Disinhibition: A loss of normal social filters, leading to inappropriate or impulsive behaviors.
  • Apathy: A loss of motivation, initiative, and interest in previously enjoyed activities. The person may seem emotionally blunted and indifferent to the feelings of others.
  • Loss of Empathy: A reduced ability to recognize or respond to the emotions of others, leading to behavior that appears cold or selfish.
  • Compulsive or Repetitive Behaviors: This can include repeating the same phrase or gesture or hoarding objects.
  • Changes in Eating Habits: Often involves a strong craving for sweet foods, overeating, and putting non-edible objects in the mouth.

2. Primary Progressive Aphasia (PPA)

This group of FTD subtypes is primarily characterized by gradual deterioration of language skills. Memory and behavior may be relatively normal in the early stages. There are different variants of PPA:

  • Nonfluent/Agrammatic Variant PPA: The primary problem is with producing speech. Speech is halting, slow, and grammatically incorrect.
  • Semantic Variant PPA: The primary problem is with understanding the meaning of words. The person may lose their vocabulary, being unable to name common objects or understand what familiar words mean.
  • Logopenic Variant PPA: The primary problem is with word-finding. The person has frequent, long pauses in their speech as they struggle to retrieve the specific word they are looking for.

Some individuals with FTD can also develop motor syndromes, with symptoms overlapping with conditions like Parkinson’s disease or Amyotrophic Lateral Sclerosis (ALS).

One of the hardest parts is that loved ones often feel like the person they knew is gone, because FTD hits behavior and personality first. I remind families: it’s the disease, not the person.

How is Frontotemporal Dementia diagnosed?

Diagnosing FTD can be extremely difficult, and misdiagnosis is common. Because it strikes at a younger age and its primary symptoms are behavioral, bvFTD is often mistaken for a psychiatric disorder, such as depression, bipolar disorder, or schizophrenia. A definitive diagnosis requires a thorough evaluation by a specialist, such as a neurologist or a psychiatrist with expertise in dementia.
The diagnostic process involves several key components:

  • A Detailed History from a Caregiver:  This is the single most important part of the evaluation. The person with FTD often has a profound lack of insight (anosognosia) and is unaware that their behavior or language has changed. A detailed account of the specific changes in personality, social conduct, empathy, and language from a spouse, child, or other close family member is essential for the doctor to suspect FTD.
  • Neurological and Neuropsychological Testing: A neurologist will perform a physical exam, and a neuropsychologist will conduct a detailed battery of tests to assess cognitive functions like memory, executive function, and language skills.
  • Brain Imaging:
    • An MRI or CT scan can show the characteristic pattern of brain shrinkage (atrophy) specifically in the frontal and/or temporal lobes.
    • A PET scan can show a decrease in glucose metabolism (energy use) in these affected brain regions.
  • Genetic Testing: If there is a family history of FTD or a related disorder, a blood test can be performed to look for mutations in the three main causative genes. Genetic counseling is essential before and after this type of testing.

FTD can look like depression, bipolar disorder, or even midlife burnout. That’s why brain imaging is so essential, it tells the real story that exams alone can miss.

How is Frontotemporal Dementia treated?

There is no cure for FTD, but symptoms can be managed with medication and support. Treatment focuses on maintaining quality of life and supporting caregivers.

Managing Behavioral Symptoms

  • Non-Pharmacological Strategies are First-Line: The most effective approach is to modify the patient’s environment and the caregiver’s approach. This includes:
    • Creating a structured, predictable daily routine.
    • Simplifying the environment to reduce confusion.
    • Using redirection and distraction rather than confrontation when challenging behaviors occur.
    • Ensuring the environment is safe by removing potential hazards.
  • Medications: Some antidepressants (SSRIs) can help with compulsive behaviors, while antipsychotic medications may be used with extreme caution due to serious side effects in dementia patients.

Managing Language Problems

A speech-language pathologist is a key member of the care team. They can help the person with PPA and their family develop alternative and augmentative communication strategies, such as using communication boards, pictures, or gestures, to maintain the ability to communicate.

Supporting the Caregiver

Caring for a person with FTD is an exceptionally demanding and emotionally draining experience. Caregivers often experience profound grief, as they are losing the person they knew long before the physical decline becomes severe.

  • Education: Learning as much as possible about the disease and understanding that the difficult behaviors are a result of brain damage, not malice, is crucial.
  • Support Groups: Connecting with other FTD caregivers through organizations like The Association for Frontotemporal Degeneration (AFTD) can provide invaluable emotional support and practical advice.
  • Respite Care: It is vital for caregivers to take regular breaks to avoid burnout and care for their own well-being.

Treatment is support, not reversal. I always say: we may not have a cure, but we can still care deeply, plan smartly, and preserve dignity every step of the way.

Conclusion

Frontotemporal Dementia is a devastating neurodegenerative disease that robs individuals of their personality, their ability to connect with others, and their capacity for language, often during the prime of their lives. Unlike Alzheimer’s, its first assault is on behavior and communication, not memory, making the diagnostic journey particularly challenging and painful for families. While there is no cure for FTD, a correct diagnosis provides an explanation for the heartbreaking changes. In my experience, FTD challenges how families relate, but love, consistency, and care continue to make a real difference in how patients experience each day.

References
  1. The Association for Frontotemporal Degeneration (AFTD). (n.d.). What is FTD? Retrieved from https://www.theaftd.org/what-is-ftd/
  2. National Institute on Aging (NIA), National Institutes of Health (NIH). (2021). What Is Frontotemporal Dementia? Retrieved from https://www.nia.nih.gov/health/what-frontotemporal-dementia
  3. National Organization for Rare Disorders (NORD). (2023). Frontotemporal Degeneration. Retrieved from https://rarediseases.org/rare-diseases/frontotemporal-degeneration/
Who are the top Frontotemporal Dementia Local Doctors?
Daniela Galimberti
Elite in Frontotemporal Dementia
Elite in Frontotemporal Dementia
Milan, IT 

Daniela Galimberti practices in Milan, Italy. Ms. Galimberti is rated as an Elite expert by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Frontotemporal Dementia, Dementia, Alzheimer's Disease, and Primary Progressive Aphasia.

Simon Ducharme
Elite in Frontotemporal Dementia
Elite in Frontotemporal Dementia
1033 Pine Avenue West, 
Montreal, QC, CA 
Languages Spoken:
English

Simon Ducharme practices in Montreal, Canada. Dr. Ducharme is rated as an Elite provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Frontotemporal Dementia, Dementia, Developmental Dysphasia Familial, and Alzheimer's Disease.

 
 
 
 
Learn about our expert tiers
Learn More
Christine Van Broeckhoven
Elite in Frontotemporal Dementia
Elite in Frontotemporal Dementia
Antwerpen, VLG, BE 

Christine Van Broeckhoven practices in Antwerpen, Belgium. Ms. Van Broeckhoven is rated as an Elite expert by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Dementia, Alzheimer's Disease, Frontotemporal Dementia, and Movement Disorders.

What are the latest Frontotemporal Dementia Clinical Trials?
Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of Oral Verdiperstat (BHV-3241) in Patients With Semantic Variant Primary Progressive Aphasia (svPPA) Due to TDP-43 Pathology

Summary: The purpose of the study is to test the safety and tolerability of twice daily Verdiperstat in patients with semantic variant primary progressive aphasia (svPPA) due to frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). Three-fourths of the participants will receive Verdiperstat and one-fourth will receive Placebo during the 24-week treatment duration.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Background: Neurodegenerative disorders can lead to problems in movement or memory. Some can cause abnormal proteins to build up in brain cells. Researchers want to understand whether these diseases have related causes or risk factors.